You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 24385-0213


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 24385-0213

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

24385-0213 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 24385-0213

Understanding the NDC Directory

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC Directory provides. The FDA's National Drug Code Directory contains comprehensive information about finished drug products, unfinished drugs, and compounded drug products. Each drug is identified by a unique three-segment NDC number, which serves as the FDA’s identifier for drugs[1].

Identifying the Drug

The NDC 24385-0213 is not explicitly mentioned in the provided sources, so we need to look up this NDC in the FDA's NDC Directory or other relevant databases to identify the drug.

General Market Analysis for Pharmaceutical Products

Market Trends and Growth

The pharmaceutical market, particularly for certain therapeutic areas, is experiencing significant growth driven by various factors. For instance, the non-small cell lung cancer (NSCLC) market is projected to grow substantially due to the increasing use of premium-priced immune checkpoint inhibitors and targeted therapies. By 2025, the NSCLC market is expected to reach $26.8 billion, with immunotherapies accounting for approximately 65% of total sales[3].

Pricing Mechanisms

Pricing for pharmaceutical products is influenced by several factors, including the Average Manufacturer Price (AMP), Unit Rebate Amount (URA), and statutory pricing formulas. For drugs sold to 340B covered entities, the 340B ceiling price is calculated by subtracting the URA from the AMP for the smallest unit of measure[5].

Specific Analysis for NDC 24385-0213

Without specific details on the drug associated with NDC 24385-0213, we can only provide a general framework for analysis.

Drug Identification

To start, one would need to search the FDA's NDC Directory to identify the proprietary name, non-proprietary name, dosage form, route of administration, and other relevant details about the drug.

Market Position

Understanding the therapeutic class and the specific market segment the drug belongs to is crucial. For example, if the drug falls under a category like NSCLC treatments, it would be part of a growing market driven by innovative therapies.

Pricing Dynamics

  • Average Manufacturer Price (AMP): This is a critical component in determining the pricing for drugs, especially for those participating in the Medicaid Drug Rebate Program.
  • Unit Rebate Amount (URA): This affects the final pricing for covered outpatient drugs sold to 340B covered entities.
  • Competitive Landscape: Analyzing the prices of similar drugs in the market can provide insights into the competitive pricing strategy.

Price Projections

Price projections would depend on various factors such as:

  • Market Demand: Growing demand in the therapeutic area.
  • Competition: Presence of generic or biosimilar alternatives.
  • Regulatory Changes: Any changes in regulatory requirements or pricing policies.
  • Innovation: Introduction of new formulations or combination therapies.

Example from Similar Markets

For instance, in the NSCLC market, drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve significant sales by 2025. Keytruda is expected to contribute $5.2 billion, Opdivo $5.5 billion, and Tecentriq $2.8 billion to the total sales of $17.5 billion for immunotherapies in this market[3].

Key Takeaways

  • Identify the Drug: Use the FDA's NDC Directory to gather detailed information about the drug.
  • Market Trends: Analyze the broader market trends in the therapeutic area the drug belongs to.
  • Pricing Mechanisms: Understand the pricing formulas and regulatory requirements affecting the drug's price.
  • Competitive Analysis: Evaluate the competitive landscape to predict pricing strategies.
  • Regulatory and Market Changes: Monitor any changes that could impact the drug's market position and pricing.

FAQs

Q: What is the National Drug Code (NDC) Directory? A: The NDC Directory is a database maintained by the FDA that contains information about finished drug products, unfinished drugs, and compounded drug products, each identified by a unique NDC number[1].

Q: How is the 340B ceiling price calculated? A: The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure[5].

Q: What factors influence the pricing of pharmaceutical products? A: Pricing is influenced by factors such as AMP, URA, competitive landscape, market demand, and regulatory changes.

Q: How can I find the specific drug associated with an NDC number? A: You can search the FDA's NDC Directory using the NDC number to find details about the drug.

Q: What is the significance of the NSCLC market in pharmaceuticals? A: The NSCLC market is significant due to its high growth rate driven by innovative therapies like immune checkpoint inhibitors and targeted therapies, projected to reach $26.8 billion by 2025[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price - Missouri Department of Social Services
  3. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
  4. NDC Directory (March 2015) - YouTube
  5. NDC Product Details - Log into 340B OPAIS - HRSA

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.